Comparison of renal transplant outcome with Neoral versus Sandimmune as part of an initial triple therapy regimen

Transplant Proc. 1998 Nov;30(7):3519-20. doi: 10.1016/s0041-1345(98)01120-8.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Administration, Oral
  • Adult
  • Antilymphocyte Serum / therapeutic use
  • Blood Transfusion
  • Cadaver
  • Cyclosporine / administration & dosage
  • Cyclosporine / therapeutic use*
  • Dosage Forms
  • Drug Therapy, Combination
  • Emulsions
  • Female
  • Follow-Up Studies
  • Graft Survival
  • Humans
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / mortality
  • Kidney Transplantation / physiology
  • Living Donors
  • Male
  • Muromonab-CD3 / therapeutic use
  • Retrospective Studies
  • Survival Analysis
  • Time Factors
  • Tissue Donors
  • Treatment Outcome

Substances

  • Antilymphocyte Serum
  • Dosage Forms
  • Emulsions
  • Muromonab-CD3
  • Cyclosporine